Study to Refine the Effectiveness of New Generation Therapies for Suicide
STRENGTHENS
STRENGTHENS: Study To Refine the Effectiveness of New Generation Therapies for Suicide
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this research study is to improve the effectiveness of a well-established therapy for suicidal thoughts and behaviors called Brief Cognitive Behavioral Therapy (BCBT) for Suicide Prevention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 29, 2026
CompletedFirst Submitted
Initial submission to the registry
September 8, 2026
CompletedFirst Posted
Study publicly available on registry
September 14, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2029
September 14, 2026
September 1, 2026
3.7 years
September 8, 2026
September 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Suicide attempts during follow-up
The primary outcome is suicide attempts during follow-up, assessed with the Self-Injurious Thoughts and Behaviors Interview-Revised (SITBI-R). SITBI-R responses will be used to determine the rate of participants making a follow-up suicide attempt (binary) and the rate of follow-up suicide attempts per participant-year across treatment arms.
From enrollment to the end of study completion at one year.
Secondary Outcomes (1)
Suicidal Cognitions and Suicidal Ideation
From enrollment to the end of study completion at one year.
Study Arms (4)
Reasons for Living
OTHERParticipants will complete reasons for living in session 2, physiological regulation in session 3, and sleep in session 4.
Sleep
OTHERSleep in session 2, physiological regulation in session 3, and reasons for living in session 4.
Cognitive Reappraisal
OTHERBeginning at week 4, participants will be classified as treatment responders if they (1) have not engaged in any preparatory behavior or made any suicide attempts (aborted, interrupted, or actual) and (2) have an SCS-R total score ≤21. Participants who do not meet these criteria will continue BCBT and be randomized a second time to determine if cognitive reappraisal or behavioral activation components are delivered next (sessions 5-9).
Behavioral Activation
OTHERBeginning at week 4, participants will be classified as treatment responders if they (1) have not engaged in any preparatory behavior or made any suicide attempts (aborted, interrupted, or actual) and (2) have an SCS-R total score ≤21. Participants who do not meet these criteria will continue BCBT and be randomized a second time to determine if cognitive reappraisal or behavioral activation components are delivered next (sessions 5-9).
Interventions
In this study, BCBT skills will be introduced in various randomly determined sequence. During the first stage, around half of participants will complete reasons for living in session 2, physiological regulation in session 3, and sleep in session 4. The other half of participants will complete these components in the reverse order: sleep in session 2, physiological regulation in session 3, and reasons for living in session 4. Treatment non-responders will continue attending BCBT sessions during Stage 2 following their 4 completed sessions in Stage 1, up to a maximum of 6 additional sessions (i.e., 10 therapy sessions total across both stages). The specific sequence of the BCBT skills used in Stage 2 will be randomly assigned.
Eligibility Criteria
You may qualify if:
- years of age or older; suicidal ideation (assessed with the SSI) and/or suicidal behavior within the past month (assessed with the SITBI-R), psychiatric hospitalization for elevated suicide risk within the past month, and/or SCS-R total score \>21; eligibility to understand and speak the English language; ability to complete the informed consent process
You may not qualify if:
- impaired mental status that precludes the ability to provide informed consent (e.g., intoxication, psychosis, mania) and/or a medical or psychiatric condition that precludes the ability to engage in outpatient therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ohio State Universitylead
- The Jordan Elizabeth Harris Foundationcollaborator
Study Sites (1)
Department of Psychiatry and Behavioral Health
Columbus, Ohio, 43210, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Melanie Bozzay, PhD
Ohio State University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Suicide Prevention, Associate Professor
Study Record Dates
First Submitted
September 8, 2026
First Posted
September 14, 2026
Study Start
April 29, 2026
Primary Completion (Estimated)
December 31, 2029
Study Completion (Estimated)
December 31, 2029
Last Updated
September 14, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared.